SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-012303
Filing Date
2018-11-09
Accepted
2018-11-09 16:01:16
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q TG10Q-Q318.htm 10-Q 982281
2 EXHIBIT 31.1 exhibit31-1.htm EX-31.1 16216
3 EXHIBIT 31.2 exhibit31-2.htm EX-31.2 16124
4 EXHIBIT 32.1 exhibit32-1.htm EX-32.1 5778
5 EXHIBIT 32.2 exhibit32-2.htm EX-32.2 5906
  Complete submission text file 0001654954-18-012303.txt   3372353

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tgtx-20180930.xml EX-101.INS 522858
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20180930.xsd EX-101.SCH 37499
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20180930_cal.xml EX-101.CAL 43591
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20180930_def.xml EX-101.DEF 100533
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20180930_lab.xml EX-101.LAB 247579
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20180930_pre.xml EX-101.PRE 185210
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 181173028
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1